USD 193.62
(-8.15%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 112.22 Million USD | 32.31% |
2022 | 90.26 Million USD | 76.59% |
2021 | 51.11 Million USD | 14.39% |
2020 | 44.68 Million USD | -17.19% |
2019 | 53.95 Million USD | 11.7% |
2018 | 48.3 Million USD | 36.13% |
2017 | 35.48 Million USD | 2.42% |
2016 | 34.65 Million USD | -7.49% |
2015 | 37.45 Million USD | 1.56% |
2014 | 36.88 Million USD | -9.27% |
2013 | 40.64 Million USD | 6.45% |
2012 | 38.18 Million USD | 5.35% |
2011 | 36.24 Million USD | 4.71% |
2010 | 34.61 Million USD | 29.55% |
2009 | 26.71 Million USD | -6.46% |
2008 | 28.56 Million USD | 25.22% |
2007 | 22.81 Million USD | 18.57% |
2006 | 19.23 Million USD | 31.75% |
2005 | 14.6 Million USD | 4.51% |
2004 | 13.97 Million USD | 30.28% |
2003 | 10.72 Million USD | -11.41% |
2002 | 12.1 Million USD | 10.8% |
2001 | 10.92 Million USD | -47.23% |
2000 | 20.7 Million USD | 20.36% |
1999 | 17.2 Million USD | 14.67% |
1998 | 15 Million USD | 6.38% |
1997 | 14.1 Million USD | 22.61% |
1996 | 11.5 Million USD | 22.34% |
1995 | 9.4 Million USD | 20.51% |
1994 | 7.8 Million USD | 5.41% |
1993 | 7.4 Million USD | 5.71% |
1992 | 7 Million USD | 0.0% |
1991 | 7 Million USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q3 | 41.52 Million USD | 25.71% |
2024 Q2 | 33.03 Million USD | 9.8% |
2024 Q1 | 30.08 Million USD | 15.13% |
2023 Q2 | 29.64 Million USD | 3.29% |
2023 Q1 | 28.7 Million USD | 23.29% |
2023 FY | 119.42 Million USD | 32.31% |
2023 Q3 | 27.75 Million USD | -6.39% |
2023 Q4 | 26.12 Million USD | -5.84% |
2022 FY | 90.26 Million USD | 76.59% |
2022 Q4 | 23.28 Million USD | -8.79% |
2022 Q3 | 25.52 Million USD | 4.93% |
2022 Q2 | 24.32 Million USD | 41.96% |
2022 Q1 | 17.13 Million USD | 31.04% |
2021 Q1 | 12.6 Million USD | 10.76% |
2021 Q4 | 13.07 Million USD | 8.81% |
2021 FY | 51.11 Million USD | 14.39% |
2021 Q3 | 12.01 Million USD | -10.42% |
2021 Q2 | 13.41 Million USD | 6.38% |
2020 FY | 44.68 Million USD | -17.19% |
2020 Q1 | 12.82 Million USD | -6.88% |
2020 Q2 | 9.94 Million USD | -22.41% |
2020 Q3 | 10.52 Million USD | 5.82% |
2020 Q4 | 11.38 Million USD | 8.13% |
2019 Q1 | 12.49 Million USD | -1.64% |
2019 Q2 | 14.37 Million USD | 15.0% |
2019 Q3 | 13.32 Million USD | -7.31% |
2019 Q4 | 13.77 Million USD | 3.38% |
2019 FY | 53.95 Million USD | 11.7% |
2018 Q4 | 12.7 Million USD | 2.21% |
2018 FY | 48.3 Million USD | 36.13% |
2018 Q3 | 12.43 Million USD | -4.27% |
2018 Q1 | 10.18 Million USD | 29.96% |
2018 Q2 | 12.98 Million USD | 27.5% |
2017 Q4 | 7.83 Million USD | -4.35% |
2017 FY | 35.48 Million USD | 2.42% |
2017 Q2 | 9.94 Million USD | 4.47% |
2017 Q1 | 9.51 Million USD | 16.28% |
2017 Q3 | 8.19 Million USD | -17.58% |
2016 Q1 | 7.72 Million USD | -14.26% |
2016 FY | 34.65 Million USD | -7.49% |
2016 Q3 | 8.45 Million USD | -17.83% |
2016 Q4 | 8.18 Million USD | -3.17% |
2016 Q2 | 10.28 Million USD | 33.12% |
2015 Q4 | 9.01 Million USD | -5.24% |
2015 FY | 37.45 Million USD | 1.56% |
2015 Q2 | 10.29 Million USD | 19.16% |
2015 Q1 | 8.63 Million USD | 0.29% |
2015 Q3 | 9.51 Million USD | -7.61% |
2014 Q4 | 8.61 Million USD | -11.05% |
2014 Q3 | 9.68 Million USD | 2.18% |
2014 Q2 | 9.47 Million USD | 4.95% |
2014 Q1 | 9.02 Million USD | -16.9% |
2014 FY | 36.88 Million USD | -9.27% |
2013 Q2 | 10.71 Million USD | 20.41% |
2013 FY | 40.64 Million USD | 6.45% |
2013 Q1 | 8.9 Million USD | -11.57% |
2013 Q3 | 10.16 Million USD | -5.19% |
2013 Q4 | 10.86 Million USD | 6.91% |
2012 Q1 | 9.2 Million USD | 2.75% |
2012 Q3 | 9.22 Million USD | -4.8% |
2012 Q4 | 10.06 Million USD | 9.12% |
2012 Q2 | 9.69 Million USD | 5.32% |
2012 FY | 38.18 Million USD | 5.35% |
2011 FY | 36.24 Million USD | 4.71% |
2011 Q4 | 8.95 Million USD | 5.55% |
2011 Q3 | 8.48 Million USD | -15.19% |
2011 Q2 | 10 Million USD | 13.66% |
2011 Q1 | 8.8 Million USD | -4.39% |
2010 FY | 34.61 Million USD | 29.55% |
2010 Q1 | 7.45 Million USD | -16.69% |
2010 Q2 | 9.04 Million USD | 21.32% |
2010 Q3 | 8.9 Million USD | -1.56% |
2010 Q4 | 9.2 Million USD | 3.37% |
2009 FY | 26.71 Million USD | -6.46% |
2009 Q2 | 5.37 Million USD | 8.66% |
2009 Q1 | 4.94 Million USD | -25.53% |
2009 Q4 | 8.95 Million USD | 20.08% |
2009 Q3 | 7.45 Million USD | 38.79% |
2008 FY | 28.56 Million USD | 25.22% |
2008 Q2 | 7.62 Million USD | 10.74% |
2008 Q1 | 6.88 Million USD | -3.3% |
2008 Q4 | 6.63 Million USD | -10.44% |
2008 Q3 | 7.41 Million USD | -2.85% |
2007 Q4 | 7.12 Million USD | 34.35% |
2007 FY | 22.81 Million USD | 18.57% |
2007 Q3 | 5.3 Million USD | -8.34% |
2007 Q2 | 5.78 Million USD | 25.77% |
2007 Q1 | 4.59 Million USD | -5.99% |
2006 FY | 19.23 Million USD | 31.75% |
2006 Q4 | 4.89 Million USD | 17.13% |
2006 Q3 | 4.17 Million USD | -21.03% |
2006 Q2 | 5.28 Million USD | 8.41% |
2006 Q1 | 4.87 Million USD | 29.59% |
2005 Q3 | 3.08 Million USD | -25.18% |
2005 Q4 | 3.76 Million USD | 21.95% |
2005 Q2 | 4.12 Million USD | 13.89% |
2005 Q1 | 3.62 Million USD | -5.91% |
2005 FY | 14.6 Million USD | 4.51% |
2004 Q4 | 3.85 Million USD | 19.67% |
2004 FY | 13.97 Million USD | 30.28% |
2004 Q2 | 3.66 Million USD | 12.92% |
2004 Q1 | 3.24 Million USD | 26.03% |
2004 Q3 | 3.21 Million USD | -12.11% |
2003 Q1 | 2.25 Million USD | -8.69% |
2003 FY | 10.72 Million USD | -11.41% |
2003 Q4 | 2.57 Million USD | -18.4% |
2003 Q3 | 3.15 Million USD | 15.1% |
2003 Q2 | 2.73 Million USD | 21.2% |
2002 Q1 | 2.87 Million USD | 6.62% |
2002 Q4 | 2.47 Million USD | -24.22% |
2002 FY | 12.1 Million USD | 10.8% |
2002 Q3 | 3.26 Million USD | -6.45% |
2002 Q2 | 3.49 Million USD | 21.58% |
2001 Q3 | 1.81 Million USD | -40.0% |
2001 FY | 10.92 Million USD | -47.23% |
2001 Q1 | 3.39 Million USD | -33.33% |
2001 Q2 | 3.02 Million USD | -11.09% |
2001 Q4 | 2.69 Million USD | 48.62% |
2000 Q4 | 5.09 Million USD | -2.18% |
2000 Q3 | 5.21 Million USD | -2.93% |
2000 Q2 | 5.36 Million USD | 6.73% |
2000 Q1 | 5.02 Million USD | 2.63% |
2000 FY | 20.7 Million USD | 20.36% |
1999 Q3 | 4 Million USD | -6.98% |
1999 Q2 | 4.3 Million USD | 7.5% |
1999 Q1 | 4 Million USD | -4.76% |
1999 FY | 17.2 Million USD | 14.67% |
1999 Q4 | 4.9 Million USD | 22.5% |
1998 Q1 | 3.3 Million USD | -15.38% |
1998 Q2 | 3.5 Million USD | 6.06% |
1998 Q3 | 4.1 Million USD | 17.14% |
1998 Q4 | 4.2 Million USD | 2.44% |
1998 FY | 15 Million USD | 6.38% |
1997 FY | 14.1 Million USD | 22.61% |
1997 Q2 | 3.4 Million USD | 6.25% |
1997 Q3 | 3.6 Million USD | 5.88% |
1997 Q1 | 3.2 Million USD | 0.0% |
1997 Q4 | 3.9 Million USD | 8.33% |
1996 Q2 | 2.9 Million USD | 20.83% |
1996 FY | 11.5 Million USD | 22.34% |
1996 Q3 | 3 Million USD | 3.45% |
1996 Q4 | 3.2 Million USD | 6.67% |
1996 Q1 | 2.4 Million USD | -4.0% |
1995 Q3 | 2.4 Million USD | 9.09% |
1995 Q4 | 2.5 Million USD | 4.17% |
1995 Q1 | 2.2 Million USD | -4.35% |
1995 Q2 | 2.2 Million USD | 0.0% |
1995 FY | 9.4 Million USD | 20.51% |
1994 Q3 | 1.8 Million USD | -10.0% |
1994 Q1 | 1.7 Million USD | -78.48% |
1994 Q2 | 2 Million USD | 17.65% |
1994 FY | 7.8 Million USD | 5.41% |
1994 Q4 | 2.3 Million USD | 27.78% |
1993 Q1 | 7.5 Million USD | 2.74% |
1993 Q2 | 7.5 Million USD | 0.0% |
1993 Q3 | 7.6 Million USD | 1.33% |
1993 Q4 | 7.9 Million USD | 3.95% |
1993 FY | 7.4 Million USD | 5.71% |
1992 Q3 | 7.3 Million USD | 0.0% |
1992 FY | 7 Million USD | 0.0% |
1992 Q4 | 7.3 Million USD | 0.0% |
1992 Q1 | 7.3 Million USD | 2.82% |
1992 Q2 | 7.3 Million USD | 0.0% |
1991 Q4 | 7.1 Million USD | 1.43% |
1991 FY | 7 Million USD | 0.0% |
1991 Q1 | 7 Million USD | 0.0% |
1991 Q2 | 7 Million USD | 0.0% |
1991 Q3 | 7 Million USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Acutus Medical, Inc. | -3.13 Million USD | 3677.463% |
Cerus Corporation | 86.4 Million USD | -29.89% |
OrthoPediatrics Corp. | 111.25 Million USD | -0.874% |
PetVivo Holdings, Inc. | 739.52 Thousand USD | -15075.261% |
Talis Biomedical Corporation | 371 Thousand USD | -30149.326% |
Vivos Therapeutics, Inc. | 8.27 Million USD | -1256.849% |
Inogen, Inc. | 126.69 Million USD | 11.424% |
Spectral AI, Inc. | 7.88 Million USD | -1324.175% |
Nano-X Imaging Ltd. | -6.59 Million USD | 1802.442% |
CVRx, Inc. | 33.03 Million USD | -239.674% |
DIH Holding US, Inc. Warrants | - USD | -Infinity% |
Helius Medical Technologies, Inc. | 61 Thousand USD | -183875.41% |
Orthofix Medical Inc. | 486.27 Million USD | 76.921% |
Venus Concept Inc. | 52.16 Million USD | -115.126% |
Accelerate Diagnostics, Inc. | 2.55 Million USD | -4300.98% |
Bioventus Inc. | 328.19 Million USD | 65.805% |
BrainsWay Ltd. | 23.09 Million USD | -386.012% |
Envoy Medical, Inc. | -473 Thousand USD | 23826.216% |
electroCore, Inc. | 13.22 Million USD | -748.518% |
IceCure Medical Ltd | 1.3 Million USD | -8532.692% |
Lucid Diagnostics Inc. | -6.05 Million USD | 1954.959% |
Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 237181.714% |
MaxCyte, Inc. | 36.54 Million USD | -207.079% |
NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -24482.874% |
Nexalin Technology, Inc. | 85.06 Thousand USD | -131836.28% |
PAVmed Inc | -3.96 Million USD | 2928.251% |
Rapid Micro Biosystems, Inc. | -5.48 Million USD | 2146.035% |
RxSight, Inc. | 53.76 Million USD | -108.732% |
Sight Sciences, Inc. | 69.17 Million USD | -62.233% |
SI-BONE, Inc. | 109.42 Million USD | -2.564% |
TELA Bio, Inc. | 40.11 Million USD | -179.779% |
TriSalus Life Sciences, Inc. | 15.9 Million USD | -605.551% |
Treace Medical Concepts, Inc. | 151.93 Million USD | 26.137% |
LivaNova PLC | 771.25 Million USD | 85.449% |
908 Devices Inc. | 25.32 Million USD | -343.192% |
Alphatec Holdings, Inc. | 310.2 Million USD | 63.822% |
Nemaura Medical Inc. | -1.47 Million USD | 7701.301% |
NeuroPace, Inc. | 48.12 Million USD | -133.209% |
LENSAR, Inc. | 21.1 Million USD | -431.696% |
Apyx Medical Corporation | 14.12 Million USD | -694.682% |
Cutera, Inc. | 41.49 Million USD | -170.461% |
STRATA Skin Sciences, Inc. | 18.46 Million USD | -507.903% |
BioSig Technologies, Inc. | 18 Thousand USD | -623372.222% |
Anika Therapeutics, Inc. | 103.08 Million USD | -8.863% |
ClearPoint Neuro, Inc. | 13.61 Million USD | -724.335% |
Integra LifeSciences Holdings Corporation | 888.39 Million USD | 87.368% |
Axonics, Inc. | 274.55 Million USD | 59.125% |
Outset Medical, Inc. | 29 Million USD | -286.983% |
IRIDEX Corporation | 21.8 Million USD | -414.628% |
PROCEPT BioRobotics Corporation | 71.04 Million USD | -57.954% |
IRadimed Corporation | 50.15 Million USD | -123.742% |
Tivic Health Systems, Inc. | 287 Thousand USD | -39002.787% |
INVO Bioscience, Inc. | 1.08 Million USD | -10232.481% |
Telesis Bio, Inc. | 16.95 Million USD | -562.094% |
Viemed Healthcare, Inc. | 112.78 Million USD | 0.495% |
Varex Imaging Corporation | 256.9 Million USD | 56.316% |
Quipt Home Medical Corp. | 163.84 Million USD | 31.505% |
Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 27741.626% |
Pulmonx Corporation | 50.75 Million USD | -121.124% |
Dynatronics Corporation | 7.63 Million USD | -1369.88% |
Modular Medical, Inc. | -768 Thousand USD | 14712.63% |
ReShape Lifesciences Inc. | 5.54 Million USD | -1922.801% |
Semler Scientific, Inc. | 61.2 Million USD | -83.374% |
InMode Ltd. | 411.34 Million USD | 72.717% |
Bruker Corporation | 1.51 Billion USD | 92.601% |
Cytosorbents Corporation | 22.39 Million USD | -401.183% |
DexCom, Inc. | 2.28 Billion USD | 95.097% |
Align Technology, Inc. | 2.71 Billion USD | 95.872% |
Viveve Medical, Inc. | 620 Thousand USD | -18000.806% |
ZimVie Inc. | 290.38 Million USD | 61.353% |
Movano Inc. | -158 Thousand USD | 71128.481% |
Cytek Biosciences, Inc. | 109.42 Million USD | -2.558% |
Nexalin Technology, Inc. | 85.06 Thousand USD | -131836.28% |
DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
Tandem Diabetes Care, Inc. | 367.69 Million USD | 69.478% |
Profound Medical Corp. | 4.51 Million USD | -2386.143% |
Insulet Corporation | 1.15 Billion USD | 90.325% |
enVVeno Medical Corporation | -546 Thousand USD | 20654.029% |
Surmodics, Inc. | 93.05 Million USD | -20.605% |
iCAD, Inc. | 14.53 Million USD | -672.049% |
Nuwellis, Inc. | 4.98 Million USD | -2152.157% |
Biotricity, Inc. | 8.35 Million USD | -1243.002% |
iRhythm Technologies, Inc. | 331.8 Million USD | 66.178% |
Aethlon Medical, Inc. | -359.05 Thousand USD | 31355.483% |
InspireMD, Inc. | 1.8 Million USD | -6110.57% |
PAVmed Inc. | -3.96 Million USD | 2928.251% |
BIOLASE, Inc. | 16.72 Million USD | -571.042% |
Beyond Air, Inc. | -1.3 Million USD | 8686.458% |
FONAR Corporation | 45.14 Million USD | -148.615% |
AxoGen, Inc. | 127.87 Million USD | 12.238% |
Vivani Medical, Inc. | -357 Thousand USD | 31535.574% |
Tactile Systems Technology, Inc. | 195.13 Million USD | 42.488% |
Inari Medical, Inc. | 434.56 Million USD | 74.175% |
QT Imaging Holdings, Inc. | - USD | -Infinity% |
Heart Test Laboratories, Inc. | 12.51 Thousand USD | -896337.415% |
Tenon Medical, Inc. | 1.24 Million USD | -8943.11% |
Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 138649.383% |
Co-Diagnostics, Inc. | 2.62 Million USD | -4171.839% |
AdaptHealth Corp. | 479.56 Million USD | 76.599% |
Sintx Technologies, Inc. | 1.84 Million USD | -5989.257% |
NanoVibronix, Inc. | 1.53 Million USD | -7201.561% |
Quanterix Corporation | 70.64 Million USD | -58.855% |
Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 27741.626% |
Sensus Healthcare, Inc. | 14.06 Million USD | -698.186% |
Pacific Biosciences of California, Inc. | 52.78 Million USD | -112.628% |
TransMedics Group, Inc. | 154.09 Million USD | 27.171% |
ReWalk Robotics Ltd. | 4.45 Million USD | -2420.211% |
NeuroMetrix, Inc. | 3.94 Million USD | -2743.001% |
Hyperfine, Inc. | 4.75 Million USD | -2259.155% |
Establishment Labs Holdings Inc. | 106.97 Million USD | -4.906% |
Biomerica, Inc. | 611 Thousand USD | -18267.43% |
Bone Biologics Corporation | - USD | -Infinity% |
AVITA Medical, Inc. | 41.68 Million USD | -169.206% |
Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 14470.226% |
Silk Road Medical, Inc | 127.08 Million USD | 11.694% |